DrugPatentWatch Database Preview
Sun Pharm Inds Ltd Company Profile
What is the competitive landscape for SUN PHARM INDS LTD, and what generic alternatives to SUN PHARM INDS LTD drugs are available?
SUN PHARM INDS LTD has one hundred and nineteen approved drugs.
There are nine US patents protecting SUN PHARM INDS LTD drugs. There are two tentative approvals on SUN PHARM INDS LTD drugs.
There are forty-six patent family members on SUN PHARM INDS LTD drugs in twenty-three countries and one hundred and forty-one supplementary protection certificates in thirteen countries.
Summary for Sun Pharm Inds Ltd
| International Patents: | 46 |
| US Patents: | 9 |
| Tradenames: | 92 |
| Ingredients: | 89 |
| NDAs: | 119 |
Drugs and US Patents for Sun Pharm Inds Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | DOXYCYCLINE | doxycycline | CAPSULE;ORAL | 065053-002 | Nov 22, 2000 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Sun Pharm Inds Ltd | FELODIPINE | felodipine | TABLET, EXTENDED RELEASE;ORAL | 091200-003 | Dec 13, 2013 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Sun Pharm Inds Ltd | CEPHALEXIN | cephalexin | CAPSULE;ORAL | 065007-002 | Sep 16, 1999 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Sun Pharm Inds Ltd | MINOCYCLINE HYDROCHLORIDE | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 091118-001 | Sep 25, 2014 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Sun Pharm Inds Ltd | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 078722-002 | May 12, 2008 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Sun Pharm Inds Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | 5,908,838 | ➤ Sign Up |
| Sun Pharm Inds Ltd | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-005 | Jul 11, 2012 | 5,908,838 | ➤ Sign Up |
| Sun Pharm Inds Ltd | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-003 | Jul 11, 2012 | 5,908,838 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for SUN PHARM INDS LTD drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
International Patents for Sun Pharm Inds Ltd Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2010017310 | ➤ Sign Up |
| Brazil | 112014026334 | ➤ Sign Up |
| South Africa | 200300990 | ➤ Sign Up |
| Japan | 2013213047 | ➤ Sign Up |
| Iceland | 6709 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Inds Ltd Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C0004 | France | ➤ Sign Up | PRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730 |
| 14/008 | Ireland | ➤ Sign Up | PRODUCT NAME: DEXLANSOPRAZOLE OR A SALT THEREOF; NAT REGISTRATION NO/DATE: PA1864/001/001-002;PA1864/002/001-002 20131125; FIRST REGISTRATION NO/DATE: 47911 47912 47913 47914 20130919 |
| 2008013,C1412357 | Lithuania | ➤ Sign Up | PRODUCT NAME: SITAGLIPTINUM PHOSPHAS MONOHYDRICUS, METFORMINI HYDROCHLORIDUM; REGISTRATION NO/DATE: EU/1/08/455/001 - EU/1/08/455/014 20080716 |
| 0625 | Netherlands | ➤ Sign Up | PRODUCT NAME: COMBINATIE BEVATTENDE ALISKIREN, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, EN AMLODIPINE, OF EEN FARMACEUATISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/11/686/001-056 20110414 |
| C0053 | Belgium | ➤ Sign Up | PRODUCT NAME: LETROZOLE; NAT. REGISTRATION NO/DATE: 206 IS 241 F 3 19970616; FIRST REGISTRATION: FR 341 474.2 1996072 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
